Literature DB >> 18824011

N-type and P/Q-type calcium channels regulate differentially the release of noradrenaline, ATP and beta-NAD in blood vessels.

Lisa M Smyth1, Ilia A Yamboliev, Violeta N Mutafova-Yambolieva.   

Abstract

Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5'-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins. omega-conotoxin GVIA abolished the evoked overflow of NA and beta-NAD in artery and vein, whereas the evoked overflow of ATP remained unchanged in the presence of omega-conotoxin GVIA. omega-agatoxin IVA significantly reduced the evoked overflow of ATP and beta-NAD. The overflow of NA remained largely unaffected by omega-agatoxin IVA, except at 16Hz in the vein where the overflow of NA was reduced by about 50%. Artery and vein exhibited similar expression levels of the alpha(1B) (CaV2.2, N-type) subunit, whereas the vein showed greater levels of the alpha(1A) (CaV2.1, P/Q-type) subunit than artery. Therefore, there are at least two release sites for NA, beta-NAD and ATP in the canine mesenteric artery and vein: an N-type-associated site releasing primarily NA, beta-NAD and some ATP, and a P/Q-type-associated site releasing ATP, beta-NAD and some NA. The N-type-mediated mechanisms are equally expressed in artery and vein, whereas the P/Q-type-mediated mechanisms are more pronounced in the vein and may ensure additional neurotransmitter release at higher levels of neural activity. In artery, beta-NAD caused a dual effect consisting of vasodilatation or vasoconstriction depending on concentrations, whereas vein responded with vasodilatation only. In contrast, ATP caused vasoconstriction in both vessels. beta-NAD and ATP may mediate disparate functions in the canine mesenteric resistive and capacitative circulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824011      PMCID: PMC2683247          DOI: 10.1016/j.neuropharm.2008.09.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  53 in total

1.  Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.

Authors:  L Smyth; J Bobalova; S M Ward; K D Keef; V N Mutafova-Yambolieva
Journal:  Auton Neurosci       Date:  2000-12-28       Impact factor: 3.145

Review 2.  Extracellular metabolism of ATP and other nucleotides.

Authors:  H Zimmermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

Review 3.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

4.  Extracellular NAD(+) induces calcium signaling and apoptosis in human osteoblastic cells.

Authors:  M Romanello; M Padoan; L Franco; V Veronesi; L Moro; P D'Andrea
Journal:  Biochem Biophys Res Commun       Date:  2001-08-03       Impact factor: 3.575

5.  Co-release of endogenous ATP and noradrenaline from guinea-pig mesenteric veins exceeds co-release from mesenteric arteries.

Authors:  J Bobalova; V N Mutafova-Yambolieva
Journal:  Clin Exp Pharmacol Physiol       Date:  2001 May-Jun       Impact factor: 2.557

6.  Agatoxin-IVA-sensitive calcium channels mediate the presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons.

Authors:  J Wang; M Irnaten; D Mendelowitz
Journal:  J Neurophysiol       Date:  2001-01       Impact factor: 2.714

Review 7.  Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers.

Authors:  H C Lee
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

8.  Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein.

Authors:  V N Mutafova-Yambolieva; B M Carolan; T K Harden; K D Keef
Journal:  Gen Pharmacol       Date:  2000-02

9.  Presynaptic alpha2-adrenoceptor-mediated modulation of adenosine 5' triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein.

Authors:  J Bobalova; V N Mutafova-Yambolieva
Journal:  J Auton Pharmacol       Date:  2001-02

10.  High-performance liquid chromatographic technique for detection of a fluorescent analogue of ADP-ribose in isolated blood vessel preparations.

Authors:  Janette Bobalova; Pavel Bobal; Violeta N Mutafova-Yambolieva
Journal:  Anal Biochem       Date:  2002-06-15       Impact factor: 3.365

View more
  6 in total

1.  Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.

Authors:  S L Demel; H Dong; G M Swain; X Wang; D L Kreulen; J J Galligan
Journal:  Neuroscience       Date:  2010-04-14       Impact factor: 3.590

2.  Storage and secretion of beta-NAD, ATP and dopamine in NGF-differentiated rat pheochromocytoma PC12 cells.

Authors:  Ilia A Yamboliev; Lisa M Smyth; Leonie Durnin; Yanping Dai; Violeta N Mutafova-Yambolieva
Journal:  Eur J Neurosci       Date:  2009-08-27       Impact factor: 3.386

Review 3.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

Review 4.  Neuronal and extraneuronal release of ATP and NAD(+) in smooth muscle.

Authors:  Violeta N Mutafova-Yambolieva
Journal:  IUBMB Life       Date:  2012-09-03       Impact factor: 3.885

5.  Release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD⁺) in the rat brain.

Authors:  Leonie Durnin; Yanping Dai; Isamu Aiba; C William Shuttleworth; Ilia A Yamboliev; Violeta N Mutafova-Yambolieva
Journal:  Eur J Neurosci       Date:  2012-01-25       Impact factor: 3.386

6.  Neurotransmitters responsible for purinergic motor neurotransmission and regulation of GI motility.

Authors:  Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  Auton Neurosci       Date:  2021-06-02       Impact factor: 2.355

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.